Response to Cottu, Bozec, Basse, and Paoletti
J Natl Cancer Inst
.
2021 Mar 1;113(3):344-345.
doi: 10.1093/jnci/djaa214.
Authors
Hua Zhang
1
,
Han Han
1
,
Tianhui He
2
,
Kristen E Labbe
1
,
Adrian V Hernandez
3
4
,
Haiquan Chen
5
,
Vamsidhar Velcheti
1
,
Justin Stebbing
6
,
Kwok-Kin Wong
1
Affiliations
1
Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
2
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
3
Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT, USA.
4
Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
5
Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
6
Department of Surgery and Cancer, Imperial College London, London, UK.
PMID:
33404597
PMCID:
PMC7936049
DOI:
10.1093/jnci/djaa214
No abstract available
Publication types
Comment
Grants and funding
NIHR-RP-011-053/DH_/Department of Health/United Kingdom